Clinical Research
Total Trials
15
As Lead Sponsor
0
As Collaborator
Total Enrollment
650
NCT01134549
Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Healthy Male Volunteers
Phase: Phase 1
Role: Collaborator
Start: Jun 9, 2010
Completion: Jul 31, 2010
NCT01383096
Study To Investigate The Relative Bioavailability of OZ439 Formulations In Healthy Volunteers
Start: Apr 30, 2012
Completion: Aug 31, 2012
NCT01728467
The Effects of RVX000222 on Glucose Metabolism in Individuals With Pre-diabetes
Phase: Phase 2
Start: Nov 30, 2012
Completion: Mar 31, 2014
NCT02280434
Phase 1 Study Accessing the Safety and Tolerability of CBP-307
Start: Nov 30, 2014
Completion: Aug 31, 2015
NCT02742766
Safety, Tolerability and Preliminary Pharmacokinetics (PK) and Pharmacodynamics (PD) of Single and Repeat Oral Doses of GSK3008356 in Healthy and Obese Subjects
Start: Mar 14, 2016
Completion: Jun 16, 2017
NCT03096756
A Study of the Safety, Tolerability and Pharmacokinetics of Orally-administered GC4702 in Healthy Volunteers
Start: Jul 26, 2016
Completion: Dec 31, 2016
NCT03361163
Controlled Human Infection for Vaccination Against Streptococcus Pyogenes
Start: Jul 10, 2018
Completion: Apr 21, 2020
NCT04323306
A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetic Profile of a Single Doses of MMV533.
Start: Aug 12, 2020
Completion: Sep 27, 2022
NCT04456634
Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile of Ruxolitinib With Artemether-lumefantrine
Start: Sep 10, 2020
Completion: Nov 17, 2020
NCT04535752
A Single and Multiple Ascending Dose Study of ANX009 in Normal Healthy Volunteers (NHV)
Start: Oct 30, 2020
Completion: Jun 26, 2021
NCT04958187
Study to Evaluate the Pharmacokinetics of ANG-3777 in Hemodialysis Subjects
Start: Jul 31, 2021
Completion: Oct 31, 2021
NCT04921254
A Study to Assess the Safety, Tolerability and Pharmacokinetics of BSG005.
Start: Aug 23, 2021
Completion: May 31, 2023
NCT05205941
MMV533 Plasmodium Falciparum Volunteer Infection Study
Start: Mar 30, 2022
Completion: Sep 2, 2022
NCT06965751
A Study on the Effects in Healthy People of a New Drug Called PDI204 for Treating COVID-19
Start: Jun 27, 2025
Completion: May 31, 2026
NCT07029932
A Phase 1 Study of the Safety and Tolerability of Single and Multiple Ascending Doses of BWC0977 in Healthy Volunteers
Start: Oct 10, 2025
Completion: Aug 30, 2026
Loading map...